Global Health Solutions(TTRX) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates Entered into a global supply, development, and license agreement with leading medical-surgical product manufacturer and distributor Medline Los Angeles, CA — November 13, 2025 — Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today reported financial results for the third quarter ended September 30, ...